Treatments

Explainer: After COVID and drug shortages, EU revamps drug laws The EU is revamping laws governing the 136 billion euro ($148 billion) pharmaceuticals industry aimed at reviving investment and boosting access to affordable drugs at a time when health budgets have been drained by the costs of treating COVID-19. Maggie Fick Reuters

...

Pandemic relief efforts did not reach immigrant families CIDRAP

Immigrant families living in the United States took some of the hardest economic hits during the COVID-19 pandemic, but benefited less from government assistance and relief programs than families with US-born caregivers.

The NIH has poured $1 billion into long Covid research — with little to show for it The federal government has burned through more than $1 billion to study long Covid, and there's basically nothing to show for it. Rachel Cohrs STAT

...

The National Institutes of Health hasn’t signed up a single patient to test any potential treatments — despite a clear mandate from Congress to study them. And the few trials it is planning have already drawn a firestorm of criticism, especially one intervention that experts and advocates say may actually make some patients’ long Covid symptoms worse.